X-rays may damage red blood cells: study seeks safe limits
NCT ID NCT07416045
First seen Jun 25, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at how X-ray irradiation used during cancer surgery affects red blood cells. Researchers will take blood from 20 patients having tumor surgery and test it with different X-ray doses. They will check for changes in cell shape, flexibility, and oxygen-carrying ability to find the safest dose for reusing the patient's own blood.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- linear accelerator X-ray irradiation
- What this could lead to
- If successful, this could help establish safe X-ray doses for processing a patient's own blood during cancer surgery, reducing risks from transfusion.
- What could go wrong
- This is a very small, early-stage study (20 participants) focused on lab measurements, not patient outcomes. Results may not translate to real-world safety or effectiveness.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ERYTHROCYTE DESTRUCTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
The Second Affiliated Hospital, School of Medicine, Zhejiang University,anesthesiology department,
RECRUITINGHangzhou, Zhejiang, 310009, China
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New drug combo aims to shrink Hard-to-Treat tumors
- Cancer gene study aims to unlock prognosis secrets
- Massive 10-Year health check: what happens when chronic diseases collide?
- New scan could sharpen cancer detection
- Smart scans may boost power of radioactive seeds against cancer
- Radiation and immunotherapy join forces in new cancer trial